Intellectual and neurological functioning in Morquio syndrome (MPS IVa)
- 10 January 2012
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 36 (2) , 323-328
Abstract
Mucopolysaccharidosis type IVa (MPS IVa, Morquio syndrome OMIM #253000) is a lysosomal storage disease caused by deficiency in N-acetylgalactosamine-6-sulfatase (GALNS, EC 3.1.6.4; encoded by GALNS gene at 16q24.3). Unlike other MPS disorders involving excessive heparan and dermatan sulfate, Morquio syndrome has not been associated with neurological involvement nor with intellectual impairment as this disorder of keratan sulfate has been described as a purely visceral and skeletal disorder. Neurocognitive assessment was undertaken of MPS IVa patients with age appropriate intellectual tests as well as a Child Behaviour Checklist as part of clinical follow up. Available neuroimaging studies (MRI and MR spectroscopy) were reviewed. Whilst more than half of the overall IQ scores fell in the average range, scores for 3/8 children fell below average. A number of behavioural problems were highlighted, including anxiety/depression, attention and somatic complaints. Subtle neuroimaging abnormalities were demonstrated in over half of the children. These findings present a challenge to existing assumptions about the nature of Morquio A syndrome. A hypothesis regarding the potential role of calcium signalling is explored.Keywords
This publication has 27 references indexed in Scilit:
- Williams syndrome hypersociability: A neuropsychological study of the amygdala and prefrontal cortex hypothesesResearch in Developmental Disabilities, 2011
- MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantationOrphanet Journal of Rare Diseases, 2011
- Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome)Journal of Inherited Metabolic Disease, 2010
- Enzyme Replacement in a Human Model of Mucopolysaccharidosis IVA In Vitro and Its Biodistribution in the Cartilage of Wild Type MicePLOS ONE, 2010
- Common and Uncommon Pathogenic Cascades in Lysosomal Storage DiseasesJournal of Biological Chemistry, 2010
- Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasisNature Chemical Biology, 2010
- Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VIPathoGenetics, 2009
- Brain Keratan Sulfate and Glial Scar FormationAnnals of the New York Academy of Sciences, 2006
- Mucopolysaccharidosis type IVA (morquio syndrome): A clinical reviewJournal of Inherited Metabolic Disease, 1995
- Calmodulin blocker inhibits Ca++-ATPase activity in secretory ameloblast of rat incisorCell and tissue research, 1987